CARDINAL HEALTH INC (CAH) Stock Analyst Earnings Estimates
NYSE:CAH - New York Stock Exchange, Inc. - US14149Y1082 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 181.364B 11.63% | 205.012B 13.04% | 226.827B 10.64% | 222.466B -1.92% | 240.934B 8.30% | 257.876B 7.03% | 274.1B 6.29% | 298.33B 8.84% | |
| EBITDA YoY % growth | 2.369B -8.88% | 2.466B 4.09% | 2.86B 15.98% | 3.189B 11.50% | 3.476B 9.00% | 3.706B 6.62% | N/A | N/A | |
| EBIT YoY % growth | 1.677B -7.71% | 1.774B 5.78% | 2.15B 21.20% | 2.627B 22.19% | 2.897B 10.28% | 3.131B 8.08% | 3.169B 1.21% | 3.284B 3.63% | |
| Operating Margin | 0.92% | 0.87% | 0.95% | 1.18% | 1.20% | 1.21% | 1.16% | 1.10% | |
| EPS YoY % growth | 5.06 -16.78% | 5.81 14.82% | 7.47 28.57% | 7.92 5.97% | 8.78 10.97% | 9.68 10.16% | 10.43 7.77% | 11.12 6.63% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.76 -3.16% | 2.22 6.95% | 2.04 10.83% | 2.01 6.68% | 2.02 14.86% | 2.41 8.38% | 2.25 10.11% | 2.17 8.02% | 2.24 10.76% | 2.74 13.73% | 2.43 8.40% |
| Revenue Q2Q % growth | 54.43B -5.25% | 54.17B -1.35% | 59.951B 0.14% | 57.471B 9.94% | 59.893B 10.04% | 58.487B 7.97% | 64.64B 7.82% | 65.24B 13.52% | 65.695B 9.69% | 63.695B 8.90% | 72.882B 12.75% |
| EBITDA Q2Q % growth | 718.77M -15.14% | 858.74M -23.67% | 804.46M -35.75% | 815.18M 10.31% | 813.56M 13.19% | 928.21M 8.09% | 881.54M 9.58% | 882.44M 8.25% | 833.57M 2.46% | 971.1M 4.62% | 959.41M 8.83% |
| EBIT Q2Q % growth | 580M 16.00% | 708.82M 17.94% | 654.04M 20.67% | 662.01M 18.85% | 650.96M 12.23% | 756.93M 6.79% | 686.65M 4.99% | 692.37M 4.59% | 715.83M 9.97% | 867.3M 14.58% | 764.65M 11.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.88 8.67% | 1.63 | 0.25 | 15.13% |
| Q4 2024 Q2Q % growth | 1.84 18.71% | 1.76 | 0.08 | 4.62% |
| Q3 2024 Q2Q % growth | 2.08 19.54% | 1.97 | 0.11 | 5.55% |
| Q2 2024 Q2Q % growth | 1.82 37.88% | 1.62 | 0.20 | 12.64% |
| Q1 2024 Q2Q % growth | 1.73 44.17% | 1.42 | 0.31 | 21.95% |
| Q4 2023 Q2Q % growth | 1.55 47.62% | 1.51 | 0.04 | 2.66% |
| Q3 2023 Q2Q % growth | 1.74 20.00% | 1.50 | 0.24 | 15.83% |
| Q2 2023 Q2Q % growth | 1.32 3.94% | 1.15 | 0.17 | 14.85% |
| Q1 2023 Q2Q % growth | 1.20 -6.98% | 0.95 | 0.25 | 26.10% |
| Q4 2022 Q2Q % growth | 1.05 -19.23% | 1.19 | -0.14 | -11.53% |
| Q3 2022 Q2Q % growth | 1.45 -5.23% | 1.54 | -0.09 | -5.87% |
| Q2 2022 Q2Q % growth | 1.27 -27.01% | 1.24 | 0.03 | 2.45% |
| Q1 2022 Q2Q % growth | 1.29 -14.57% | 1.34 | -0.05 | -3.68% |
| Q4 2021 Q2Q % growth | 1.30 25.00% | 1.21 | 0.09 | 7.29% |
| Q3 2021 Q2Q % growth | 1.53 -5.56% | 1.57 | -0.04 | -2.38% |
| Q2 2021 Q2Q % growth | 1.74 14.47% | 1.46 | 0.28 | 19.40% |
| Q1 2021 Q2Q % growth | 1.51 18.90% | 1.14 | 0.37 | 31.93% |
| Q4 2020 Q2Q % growth | 1.04 -6.31% | 0.93 | 0.11 | 12.43% |
| Q3 2020 Q2Q % growth | 1.62 1.89% | 1.45 | 0.17 | 11.94% |
| Q2 2020 Q2Q % growth | 1.52 17.83% | 1.23 | 0.29 | 23.28% |
| Q1 2020 Q2Q % growth | 1.27 -1.55% | 1.11 | 0.16 | 14.87% |
| Q4 2019 Q2Q % growth | 1.11 | 0.94 | 0.17 | 18.32% |
| Q3 2019 Q2Q % growth | 1.59 | 1.44 | 0.15 | 10.33% |
| Q2 2019 Q2Q % growth | 1.29 | 1.10 | 0.19 | 17.41% |
| Q1 2019 Q2Q % growth | 1.29 | 1.09 | 0.20 | 18.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 52.277B -4.54% | 51.404B | 873M | 1.70% |
| Q4 2024 Q2Q % growth | 59.867B 12.00% | 59.285B | 582M | 0.98% |
| Q3 2024 Q2Q % growth | 54.911B 8.76% | 56.615B | -1.704B | -3.01% |
| Q2 2024 Q2Q % growth | 57.445B 11.61% | 57.583B | -138M | -0.24% |
| Q1 2024 Q2Q % growth | 54.763B 10.40% | 55.306B | -543M | -0.98% |
| Q4 2023 Q2Q % growth | 53.453B 13.57% | 53.246B | 207M | 0.39% |
| Q3 2023 Q2Q % growth | 50.487B 12.60% | 50.206B | 281M | 0.56% |
| Q2 2023 Q2Q % growth | 51.469B 13.23% | 51.251B | 218M | 0.43% |
| Q1 2023 Q2Q % growth | 49.603B 12.82% | 48.668B | 935M | 1.92% |
| Q4 2022 Q2Q % growth | 47.065B 10.52% | 45.161B | 1.904B | 4.22% |
| Q3 2022 Q2Q % growth | 44.836B 14.16% | 43.591B | 1.245B | 2.86% |
| Q2 2022 Q2Q % growth | 45.457B 9.43% | 46.028B | -571M | -1.24% |
| Q1 2022 Q2Q % growth | 43.968B 12.55% | 42.352B | 1.616B | 3.82% |
| Q4 2021 Q2Q % growth | 42.586B 16.07% | 40.828B | 1.758B | 4.31% |
| Q3 2021 Q2Q % growth | 39.275B 0.30% | 40.494B | -1.219B | -3.01% |
| Q2 2021 Q2Q % growth | 41.541B 4.55% | 41.852B | -311M | -0.74% |
| Q1 2021 Q2Q % growth | 39.065B 4.62% | 38.559B | 506M | 1.31% |
| Q4 2020 Q2Q % growth | 36.689B -1.78% | 37.04B | -351M | -0.95% |
| Q3 2020 Q2Q % growth | 39.157B 11.15% | 37.316B | 1.841B | 4.93% |
| Q2 2020 Q2Q % growth | 39.735B 5.29% | 39.826B | -91M | -0.23% |
| Q1 2020 Q2Q % growth | 37.341B 6.04% | 37.115B | 226M | 0.61% |
| Q4 2019 Q2Q % growth | 37.353B | 37.183B | 170M | 0.46% |
| Q3 2019 Q2Q % growth | 35.228B | 35.547B | -319M | -0.90% |
| Q2 2019 Q2Q % growth | 37.74B | 36.46B | 1.28B | 3.51% |
| Q1 2019 Q2Q % growth | 35.213B | 33.991B | 1.222B | 3.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.13% | 0% | 2.74% |
| Revenue | 0% | 0.9% | 0.01% | 1.72% |